We sit down with you and build your perfect lead list. Book a call with founders.

Diffuse Bio Analysis

What is Diffuse Bio?

Diffuse Bio develops generative AI for protein design, enabling the engineering of new proteins with exceptional control and precision.

Employees
10
Founded
2022
Revenue
$1.5M
Company Stage
Seed
Investors
- Y Combinator - GreatPoint Ventures - Fellows Fund
YC Batch
W23

Product Features & Capabilities

  • generative AI for protein design, Diffuse StructGen-1 (DSG-1) for designing nanobody binders, achieving a hit rate of 3%, capable of designing strong binders in the <=10nM range, computational design of therapeutics, vaccines, and enzymes, overcoming limitations of existing computational protein des

Find more companies like Diffuse Bio

in Y Combinator Batch W23 Companies